Further analysis of human skeletal muscle transcript profile of biopsies from patients diagnosed with DMD and controls revealed a strong positive correlation between different transcripts of the sphingolipid de novo biosynthesis pathway (Fig. 2A), except for CERS1 and CERS6. The gene discussed is CERS6; the disease is Duchenne muscular dystrophy.